跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 173 条关于
“FIGO”
全部
173
临床试验
137
药物
4
机构
2
资讯
30
2年前
Pembrolizumab Plus Chemotherapy Demonstrates DFS Benefit in dMMR Endometrial Cancer Subgroup
去年
PD-L1 Expression Correlates with HRD Status and Predicts Survival in High-Grade Serous Ovarian Cancer
去年
TRUST Trial Shows Primary Surgery Improves Progression-Free Survival in Advanced Ovarian Cancer Despite Missing Overall Survival Endpoint
去年
Novel Therapies and Combinations Lead the Way in Women's Cancers in 2024
2年前
Pembrolizumab Fails to Improve DFS in High-Risk Endometrial Cancer, Shows Promise in dMMR Subgroup
去年
HSP60 Expression Levels Emerge as Critical Prognostic Marker in Ovarian Cancer Study
去年
Preoperative Immunonutritional Status Emerges as Critical Predictor of Ovarian Cancer Outcomes in Large Chinese Study
去年
NRG258 Trial: Chemoradiation Fails to Improve Overall Survival in Advanced Endometrial Cancer
去年
Novel Pan-Immune-Inflammation Nomogram Shows Promise in Predicting Epithelial Ovarian Cancer Outcomes
去年
Keytruda Regimens Receive Positive CHMP Opinion for Gynecologic Cancers in EU
第 1 页,共 3 页
上一页
下一页